QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors.
Department of Pharmacy, S.G.S.I.T.S., Indore 452003, Madhya Pradesh, India.
Journal Article: Bioorganic & Medicinal Chemistry Letters (impact factor: 2.65). 01/2005; 14(24):6089-94. DOI: 10.1016/j.bmcl.2004.09.068
Abstract
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
Bioorganic & medicinal chemistry letters. 14(15):4005-11.
Dihydroorotate dehydrogenase inhibitors: quantitative structure-activity relationship analysis.
Pharmaceutical research. 15(2):286-95.
Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
Journal of computer-aided molecular design. 19(4):229-42.
Relevance of theoretical molecular descriptors in quantitative structure-activity relationship analysis of alpha1-adrenergic receptor antagonists.
Bioorganic & medicinal chemistry. 7(11):2437-51.
Quantitative structure-activity relationship analysis of aryl alkanol piperazine derivatives with antidepressant activities.
European journal of medicinal chemistry.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Science & Research Jobs
PRAS-Healthcare-Scientist for MRI Coil Design
Position: Other
Employer: Philips (China) Investment Co.,Ltd
W3-Professur für molekulare Grundlagen thorakaler Tumoren
Position: Professor (Full)
Employer: Deutsches Krebsforschungszentrum (D...

